Search Results - "Bouterfa, H"

Refine Results
  1. 1

    Metabolic effects of amino acid solutions infused for renal protection during therapy with radiolabelled somatostatin analogues by Barone, Raffaella, Pauwels, Stanislas, De Camps, Joëlle, Krenning, Eric P., Kvols, Larry K., Smith, M. Charles, Bouterfa, Hakim, Devuyst, Olivier, Jamar, François

    Published in Nephrology, dialysis, transplantation (01-09-2004)
    “…Background. Infusion of amino acids (AAs) can reduce renal uptake of radiolabelled somatostatin analogues resulting in a lower kidney exposure during peptide…”
    Get full text
    Journal Article
  2. 2

    Organization and expression of H1 histone and H1 replacement histone genes by Doenecke, D, Albig, W, Bouterfa, H, Drabent, B

    Published in Journal of cellular biochemistry (01-04-1994)
    “…The H1 family is the most divergent subgroup of the highly conserved class of histone proteins [Cole: Int J Pept Protein Res 30:433-449, 1987]. In several…”
    Get more information
    Journal Article
  3. 3

    Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells by Bouterfa, H L, Sattelmeyer, V, Czub, S, Vordermark, D, Roosen, K, Tonn, J C

    Published in Anticancer research (01-07-2000)
    “…Malignant astrocytomas are the most common primary intracranial human tumors. All therapeutic approaches are limited due to their high proliferative capacity…”
    Get more information
    Journal Article
  4. 4

    Early increase in histone H1(0) mRNA during differentiation of F9 cells to parietal endoderm by Alonso, A., Breuer, B., Bouterfa, H., Doenecke, D.

    Published in The EMBO journal (01-10-1988)
    “…We have isolated and characterized cDNA clones coding for the H1 histone subtype H1(0) in mouse teratocarcinoma cells. The mRNA is 2100 nt long and contains a…”
    Get full text
    Journal Article
  5. 5

    Isolation of two murine H1 histone genes and chromosomal mapping of the H1 gene complement by Drabent, B, Franke, K, Bode, C, Kosciessa, U, Bouterfa, H, Hameister, H, Doenecke, D

    Published in Mammalian genome (01-08-1995)
    “…The mammalian H1 histone gene complement consists of at least seven H1 protein isoforms. These include five S-phase-dependent H1 protein subtypes and two more…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Effect of changes in the CD44 gene on tumour cell invasion in gliomas by BOUTERFA, H, JANKA, M, MEESE, E, KERKAU, S, ROOSEN, K, TONN, J. C

    Published in Neuropathology and applied neurobiology (01-10-1997)
    “…Cell adhesion is a critical factor in the multistep process of tumour invasion. CD44 is one of the cell surface adhesion molecules responsible for interaction…”
    Get full text
    Conference Proceeding Journal Article
  8. 8

    Effects of insulin-like growth factor II on the generation of inositol trisphosphate, diacylglycerol and cAMP in human fibroblasts by Damke, H, Bouterfa, H, Braulke, T

    Published in Molecular and cellular endocrinology (01-03-1994)
    “…In human fibroblasts, exogenous insulin-like growth factor-II (IGF-II) induce a rapid redistribution of mannose 6-phosphate/IGF-II receptors. To analyze the…”
    Get more information
    Journal Article
  9. 9

    Long-Acting Octreotide and Prolonged-Release Lanreotide Formulations Have Different Pharmacokinetic Profiles by Astruc, Beatrice, Marbach, Peter, Bouterfa, Hakim, Denot, Caroline, Safari, Mitra, Vitaliti, Alessandra, Sheppard, Michael

    Published in Journal of clinical pharmacology (01-07-2005)
    “…Single‐dose pharmacokinetic (PK) profiles and multiple‐dose PK modeling were compared for long‐acting octreotide (20 or 60 mg) and prolonged‐release lanreotide…”
    Get full text
    Journal Article
  10. 10

    World-wide medical treatment practice in functional gastro-entero-pancreatic (GEP) tumors: The GEPTOSIS study by Pavel, M., Silva, A., Schupp, J., Bouterfa, H.

    Published in Journal of clinical oncology (20-06-2006)
    “…Abstract only 14097 Background: Because of their efficacy and safety profile, somatostatin analogues have become the preferred medical therapy for symptom…”
    Get full text
    Journal Article
  11. 11

    Effect of synthetic matrix‐metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas In vitro by Tonn, Joerg‐Christian, Kerkau, Siglinde, Hanke, Anne, Bouterfa, Hakim, Mueller, Justus G., Wagner, Sven, Vince, Giles Hamilton, Roosen, Klaus

    Published in International journal of cancer (01-03-1999)
    “…Glioma invasion into the surrounding brain tissue is still a major obstacle for any therapeutical approach. As in other solid tumors, matrix‐metalloproteases…”
    Get full text
    Journal Article
  12. 12

    Retinoids inhibit human glioma cell proliferation and migration in primary cell cultures but not in established cell lines by Bouterfa, H, Picht, T, Kess, D, Herbold, C, Noll, E, Black, P M, Roosen, K, Tonn, J C

    Published in Neurosurgery (01-02-2000)
    “…Retinoids are known to exhibit a broad spectrum of biological activities, and they participate in the onset of differentiation and the inhibition of growth in…”
    Get full text
    Journal Article
  13. 13

    Potential role for retinoic acid receptor-γ in the inhibition of breast cancer cells by selective retinoids and interferons by FANJUL, A. N, BOUTERFA, H, DAWSON, M, PFAHL, M

    Published in Cancer research (Chicago, Ill.) (01-04-1996)
    “…Retinoids are known to inhibit the growth of a wide variety of cancer cells, including breast cancer cells. Advances made in recent years in the understanding…”
    Get full text
    Journal Article
  14. 14

    Expression of different extracellular matrix components in human brain tumor and melanoma cells in respect to variant culture conditions by BOUTERFA, H, DARLAPP, A.-R, KLEIN, E, PIETSCH, T, ROOSEN, K, TONN, J. C

    Published in Journal of neuro-oncology (01-08-1999)
    “…Local tumor invasion into the surrounding brain tissue is a major characteristic of malignant gliomas. These processes critically depend on the interaction of…”
    Get full text
    Journal Article
  15. 15

    Dissecting glioma invasion: interrelation of adhesion, migration and intercellular contacts determine the invasive phenotype by Kaczmarek, Elzbieta, Zapf, Svenja, Bouterfa, Hakim, Tonn, Jörg C., Westphal, Manfred, Giese, Alf

    “…The invasive cellular behavior of malignant gliomas is determined by receptor mediated cell–substratum contacts and cell–cell interaction as well as cellular…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Inverse correlation of cell proliferation and expression of progesterone receptors in tumor spheroids and monolayer cultures of human meningiomas by Tonn, J C, Ott, M M, Bouterfa, H, Kerkau, S, Kapp, M, Müller-Hermelink, H K, Roosen, K

    Published in Neurosurgery (01-11-1997)
    “…The progesterone receptor (PgR) can be detected in 60 to 70% of meningiomas using immunohistochemistry] in situ. Whereas in monolayer tissue cultures the PgR…”
    Get full text
    Journal Article
  18. 18

    Effect of changes in the CD44 gene on tumour cell invasion in gliomas by Bouterfa, H., Janka, M., Meese, E., Kerkau, S., Roosen, K., Tonn, J. C.

    Published in Neuropathology and applied neurobiology (01-10-1997)
    “…H. Bouterfa, M. Janka, E. Meese, S. Kerkau, K. Roosen & J. C. Tonn (1997) Neuropathology and Applied Neurobiology23, 373–379 Effect of changes in the CD44 gene…”
    Get full text
    Journal Article
  19. 19

    Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10 by WAGNER, S, STEGEN, C, BOUTERFA, H, HUETTNER, C, KERKAU, S, ROGGENDORF, W, ROOSEN, K, TONN, J.-C

    Published in Journal of neuro-oncology (01-11-1998)
    “…Matrix metalloproteinases have been implicated to play a vital role in glioma invasion as they degrade extracellular matrix to facilitate the subsequent…”
    Get full text
    Journal Article
  20. 20